Replies to post #42184 on OncoSec Medical Inc (ONCSQ)

[InTheTrenches]

Thank you, hschlauch.

Looking forward to your take on HALO. While HALO is very intriguing, my untrained view is that pegPh20 is an incremental improvement, while ONCS may well be a quantum leap. Especially if multigene constructs, like your ideas on CD4-positive T regs/FOXP3, leads to complete responses in nearly all melanoma patients.

[chickpea598]

hschlauch, I am just speculating on the collaborator for the PIIM construct. Jounce is currently using Oncosec's GENESIS technology in pre clinical work. Do you think Jounce would be a likely partner for the new PIIM construct? They have a deep collaboration with Celgene in solid tumors. Seems logical to me that they might take more interest in Oncosec after the recent positive SITC data on the multigene construct. What is your take if any? Thanks for any insight you can give on this.